Vikas Lifecare Limited (VIKASLIFE) Fair Value & Analysis
Consumer Defensive · IN · Market cap ₹2.2B
Strengths
Risks
Fair value as of: Aug 24, 2026
From 18 valuation models · updated today
Share price −7.6% over the past month.
Below-average quality, trading 38% below our fair value.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
What matters now
- The price is below even our cautious bear case (₹1.74). The market is more pessimistic than our downside scenario.
- Solid quality (46/100) at a price below fair value, the discount is the argument here, not the business quality.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 24, 2026.
How to read this chart
60‑month range ₹1.06 – ₹7.97 · fair‑value band ₹1.74 – ₹2.11 · the ₹1.22 price screens below the ₹1.96 fair value. Dashed = 300-day average. As of Aug 24, 2026.
Analysis
Vikas Lifecare Limited (VIKASLIFE) currently trades at ₹1.22, while our model-based Fair Value estimate is ₹1.96, implying the stock looks roughly 60.7% undervalued today. The Quality Score stands at 46/100 (below-average quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.
Over the trailing twelve months, Vikas Lifecare Limited generated revenue of ₹5.0B at a net margin of 3.7%. Revenue grew 24.7% year over year. It earns a return on equity of 3.4%. Net debt stands at ₹1.0B. Fundamentals as of Aug 24, 2026
Our scenario range runs from ₹1.74 (bear case) to ₹2.11 (bull case); at ₹1.22, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 49% below its 52-week high and 16% above its 52-week low, currently below its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at -19% fair-value upside, at 61%, VIKASLIFE screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 18 models by family
Widest divergence: Growth DCF (₹13.42) versus Multiples (₹1.68). Highest evidence: Growth DCF (80).
Notify me when VIKASLIFE reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 24, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 52 · Market factors (momentum, volatility) 29
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
All values are scores from 0 to 100 (100 = best against fixed, research-based bands), not percentages. The three market factors (momentum, 52-week proximity, low volatility) are displayed but carry zero weight in the headline number: market sentiment is not a business property.
About the company
Vikas Lifecare Limited engages in the trading of polymers and chemicals, iron and steel, and plastic products in India, Mauritius, and Bangladesh. The company operates through Real Estate Division; Trading & Manufacturing Division -Agro; Trading & Manufacturing Division -Polymers; and Trading Division -Infrastructure.
Full company description
Vikas Lifecare Limited engages in the trading of polymers and chemicals, iron and steel, and plastic products in India, Mauritius, and Bangladesh. The company operates through Real Estate Division; Trading & Manufacturing Division -Agro; Trading & Manufacturing Division -Polymers; and Trading Division -Infrastructure. It trades base polymers, additive, and chemicals for plastic processing; polymer compounds, including EVA, PVC, PP, and PE, as well as V blend SOE compound, polypropylene compounds, and thermo plastic rubber compound. The company is involved in developing smart products comprising smart gas meters and power distribution solutions; supplying of food grade piping systems for drinking water; infrastructure products, such as drinking water pipes, fittings, and bars; trading of agro products, including rice and pulses; dealing of raw and finished cashew nuts, dry fruits, and other premium consumer products. In addition, it engages in research and development of horticultural, cultivation, and preservation and storage of agro products; aluminium foils; and processed food products. The company also exports its products. The company was formerly known as Vikas Multicorp Limited and changed its name to Vikas Lifecare Limited in April 2021. The company was incorporated in 1995 and is based in New Delhi, India.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
Vikas Lifecare Limited reported revenue of ₹5.0B in FY2026 versus ₹3.0B in FY2022, a compound +13.5%/yr. Reported net income was ₹184M in FY2026, compounding −10.5%/yr from FY2022.
Watch VIKASLIFE: get an alert when its fair value changes →
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Farm Products stocks, each showing price versus our Fair Value estimate (as of Aug 24, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Archer-Daniels-Midland Company ADM | $80.76 | $38.02 | -53% |
| Muyuan Foods Group 002714 | ¥40.15 | ¥47.42 | +18% |
| Bunge Global SA BG | $111.75 | $56.19 | -50% |
| Tyson Foods, Inc TSN | $57.99 | $28.60 | -51% |
| Wens Foodstuff Group 300498 | ¥13.80 | ¥11.18 | -19% |
| Mowi ASA MOWI | kr 206.00 | kr 260.70 | +27% |
| Fujian Wanchen Food Group 300972 | ¥201.06 | ¥143.09 | -29% |
| United Plantations Berhad 2089 | 32.60 MYR | 23.34 MYR | -28% |
| Charoen Pokphand Foods Public Company CPF | 23.40 THB | 43.24 THB | +85% |
| PT Charoen Pokphand Indonesia Tbk, CPIN | 2,960 IDR | 6,818 IDR | +130% |
Compare Vikas Lifecare Limited with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Consumer Defensive stocks →
Discover undervalued stocks
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Vikas Lifecare Limited (VIKASLIFE) overvalued or undervalued?
What is the fair value of VIKASLIFE?
What is the quality score of VIKASLIFE?
What is the revenue of Vikas Lifecare Limited (VIKASLIFE)?
What is the net profit margin of VIKASLIFE?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Vikas Lifecare Limited and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.